Progyny, Inc.
PGNY
$31.72
-$0.35-1.09%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 25.95% | 36.77% | 43.27% | 50.04% | 68.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.95% | 36.77% | 43.27% | 50.04% | 68.03% |
| Cost of Revenue | 25.45% | 36.95% | 44.74% | 43.43% | 65.79% |
| Gross Profit | 27.87% | 36.15% | 38.18% | 77.97% | 77.16% |
| SG&A Expenses | 4.63% | 27.91% | 29.70% | 32.18% | 62.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.38% | 35.33% | 41.91% | 41.28% | 65.19% |
| Operating Income | 317.42% | 61.61% | 71.80% | 25,981.03% | 1,858.51% |
| Income Before Tax | 292.71% | 81.39% | 92.82% | 11,600.70% | 1,140.45% |
| Income Tax Expenses | 280.90% | 401.02% | 1,511.85% | 73.66% | 104.74% |
| Earnings from Continuing Operations | 295.25% | 20.34% | 70.97% | 255.62% | -77.40% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 295.25% | 20.34% | 70.97% | 255.62% | -77.40% |
| EBIT | 317.42% | 61.61% | 71.80% | 25,981.03% | 1,858.51% |
| EBITDA | 284.70% | 60.96% | 70.33% | 4,982.35% | 2,831.25% |
| EPS Basic | 283.33% | 16.35% | 66.00% | 246.32% | -78.03% |
| Normalized Basic EPS | 264.23% | 62.11% | 73.80% | 35,266.67% | 887.88% |
| EPS Diluted | 364.57% | 23.08% | 66.67% | 260.00% | -79.89% |
| Normalized Diluted EPS | 274.27% | 66.11% | 77.20% | 33,033.33% | 931.03% |
| Average Basic Shares Outstanding | 3.14% | 3.45% | 3.02% | 2.65% | 2.78% |
| Average Diluted Shares Outstanding | 0.69% | 1.06% | 0.95% | 0.23% | -0.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
